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Background: Many symbiotic nitrogen fixation 
genes are regulated by FixK-like proteins.  
Results: The high-resolution structure of a 
rhizobial FixK-DNA complex was solved.  
Conclusion: The structure explains how 
oxidation of a surface-exposed cysteine near the 
DNA-binding site interferes with transcription 
activation.  
Significance: Post-translational modification of 
a transcription regulator by reactive oxygen 
species is a means to shut off gene expression.  
 
SUMMARY 
FixK2 is a regulatory protein that activates 
a large number of genes for the anoxic and 
microoxic, endosymbiotic and nitrogen-fixing 
life styles of the α-proteobacterium 
Bradyrhizobium japonicum. FixK2 belongs to 
the cyclic AMP receptor protein (CRP) 
superfamily. While most CRP-family 
members are co-regulated by effector 
molecules, the activity of FixK2 is negatively 
controlled by oxidation of its single cysteine 
(C183) located next to the DNA binding 
domain, and possibly also by proteolysis. 
Here we report the three-dimensional X-ray 
structure of FixK2, a representative of the 
FixK subgroup of the CRP superfamily. 
Crystallization succeeded only (i) when an 
oxidation- and protease-insensitive protein 
variant (C183S-FixK2His6) was used, in which 
C183 was replaced by serine and the C-
terminus fused with a hexa-histidine tag, and 
(ii)  when this protein was allowed to form a 
complex with a 30mer double-strand target 
DNA. The structure of the FixK2-DNA 
complex was solved at a resolution of 1.77 Å 
in which the protein formed a homodimer. 
The precise protein-DNA contacts were 
identified which led to an affirmation of the 
canonical target sequence, the so-called FixK2 
box. The C-terminus is surface-exposed which 
might explain its sensitivity to specific 
cleavage and degradation. The oxidation-
sensitive C183 is also surface-exposed and in 
close proximity to DNA. Therefore, we 
propose a mechanism whereby the oxo-acids 
generated after oxidation of the cysteine thiol 
cause an electrostatic repulsion, thus 
preventing specific DNA binding.  
 
 
The CRP/FNR3 superfamily of transcription 
factors comprises an important group of 
regulatory proteins that are widely distributed 
within bacteria. The name-giving proteins of this 
family are: the cyclic AMP receptor protein 
(CRP; 1) and the fumarate and nitrate reductase 
regulator (FNR; 2). Members of this superfamily 
disparately respond to a broad range of 
metabolic and environmental cues, thereby 
regulating a huge number of genes involved in 
vital functions such as carbon substrate 
utilization, virulence, nitrogen fixation, 
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photosynthesis, and various modes of respiratory 
electron transport (3). Most of the CRP/FNR-
type regulators function as transcription 
activators, few as repressors, and their regulatory 
activity is generally modulated by the binding of 
effector molecules (i.e., cofactors, prosthetic 
groups; 3). 
Despite a remarkably low sequence identity 
(<25%) among the family members, the proteins 
are predicted to be structurally similar to the 
CRP protein. They all share an N-terminally 
located effector binding domain, an anti-parallel 
β-barrel that makes contact with the RNA 
polymerase, a long α helix that enables 
dimerization, and a C-terminally positioned 
DNA-binding domain with a helix-turn-helix 
(HTH) motif. Being active as homodimers, the 
proteins bind to a 2-fold symmetric consensus 
nucleotide sequence on target DNA at distinct 
distances upstream of the promoters of regulated 
genes (1–5). 
Based on the primary structures of the DNA-
binding and effector-binding domains, the 
CRP/FNR members have been classified into 21 
subgroups (3). Up to now, the following eight 
proteins, representing seven subgroups, have 
been crystallized and structurally characterized 
(PDB numbers in parentheses): CRP (3HIF; 6), 
CLP (3IWZ; 7), DNR (3DKW; 8), CooA (1FT9; 
9), CprK (3E6C; 10), PrfA (2BE0; 11), NtcA 
(3LA2; 12), and SdrP (2ZCW; 13). However, no 
structures are known for proteins belonging to 
other important subgroups such as FNR, FixK, 
FnrN, and NnrR. A recent structural comparison 
of proteins in the on- and the off-states (6, 10, 
12, 14, 15) have allowed a better understanding 
of the allosteric mechanism triggered by the 
binding of cofactors, and have suggested that the 
cofactor-induced activation mechanism is 
different within each subgroup.  
The Bradyrhizobium japonicum FixK2 
protein (16, 17) is a key regulator for the control 
of >200 genes required for microoxic, anoxic, 
and symbiotic growth. In root-nodule symbiosis 
with soybean the bacterium fixes molecular 
nitrogen. FixK2 belongs to the FixK subgroup of 
the CRP/FNR superfamily but – as opposed to 
other superfamily members – evidence for the 
involvement of a co-regulator in modulating the 
transcription-activating activity is missing. The 
FixK2 amino acid sequence lacks a predicted 
binding site for a cofactor, and more 
importantly, purified protein from aerobically 
grown FixK2-overproducing Escherichia coli 
cells is active as a homodimer in an in vitro 
transcription (IVT) activation assay without a 
recognizable co-activator (18). Yet, FixK2 
activity is influenced, but in a different way. Due 
to unique cysteine at position 183 near the HTH 
motif of the DNA-binding domain, FixK2 is 
oxidation-sensitive. Oxidation of this cysteine in 
vitro triggers the formation of a reversible 
intermolecular disulfide bridge between two 
monomers. In vivo, however, the more likely 
oxidation mechanism is the conversion of the 
cysteine thiol into a sulfenic, sulfinic or sulfonic 
acid which inactivates the protein (19). The 
relevance of FixK2 oxidation in vivo is based on 
indirect evidence. In particular, microarray 
analysis had shown that most of the direct, 
FixK2-activatable target genes displayed a 
decreased expression in hydrogen peroxide-
stressed B. japonicum wild-type cells, but not in 
a strain having a FixK2 variant with a 
replacement of cysteine 183 by an alanine (19). 
FixK2 oxidation might be relevant for instantly 
shutting off its activity in response to reactive 
oxygen species (ROS) in vivo. ROS are 
produced (i) in the early stage of root-hair 
infection, (ii) in the process of endosymbiotic 
respiration, and (iii) late during nodule 
senescence (20-22). In all of these conditions 
FixK2 activity might either not be necessary or 
not desirable. Apart from this oxidative, post-
translational control FixK2 is also subject to 
proteolysis. We have recently shown that FixK2 
is degraded by the housekeeping chaperone 
protease ClpAP1 and that the preferential 
protease-sensitive site is located at the carboxy-
terminus (23). 
It was therefore of interest to crystallize 
FixK2 and to determine its structure by X-ray 
crystallography. We hoped that this would help 
us understand how the oxidation of cysteine 183 
interferes with FixK2 activity and why the C-
terminus is prone to proteolysis. Moreover, as it 
turned out that crystals were formed only when 
FixK2 was complexed with DNA, the structure 
also uncovered the precise protein-DNA contact 
sites.   
 
EXPERIMENTAL PROCEDURES   
Plasmid construction. The QuikChange site-
directed mutagenesis method (Stratagene, Basel, 
Switzerland) was used to exchange the codon for 
cysteine 183 against a serine codon, using the 
complementary oligonucleotides (5'-
GATGGCGCTGCCGATGTCCCGCCGCGAT
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ATCGGCG-3' and 3'-
CGCCGATATCGCGGCGGGACATCGGCAG
CGCCATC-5' (serine codons underlined) and 
pRJ9058 (18) as template, which yielded 
plasmid pRJ8848. To construct the plasmid 
coding for the N-terminally fused, His6-tagged 
C183S-FixK2, the fixK2-containing DNA 
fragment was cut out with NdeI and NotI 
restriction enzymes and cloned in frame with the 
His6-tag DNA into pET28b(+) (Novagen, 
Nottingham, UK), yielding plasmid pRJ8850. To 
obtain C-terminally fused, His6-tagged C183S-
FixK2, the fixK2 gene was first amplified by PCR 
from pRJ8848 with appropriate primers 
(forward: 5'-
GCGCATATGCTGACCCAGACAC-3'; 
reverse: 5'-
CGGCGGCCGCGGCGTCGAGATTGTGCAG
GC-3') which contained sequences for the NdeI 
and NotI restriction sites (underlined). The PCR-
amplified DNA was then cloned in the pGEM-T 
easy vector (Promega, Madison, USA), cut out 
with the aforementioned enzymes, and cloned in 
frame with the His6-tag DNA into pET24c(+) 
(Novagen), yielding the consecutive plasmids 
pRJ0003 and pRJ0004. All fusion constructs 
were confirmed by sequencing. 
Protein expression and purification. C183S-
His6FixK2 and C183S-FixK2His6 proteins, 
carrying the N- and C-terminal His6-tags, 
respectively, were expressed and purified as 
described previously (18), unless specified 
otherwise (see crystallization part). 
Selenomethionine-labeled C183S-FixK2His6 
(SeMet C183S-FixK2His6) was generated using 
the methionine auxotrophic E. coli B834 (DE3) 
strain (Novagen). The recombinant strain was 
grown in SelenoMetTM medium (Molecular 
Dimensions Ltd., Newmarket, UK) at 30°C for 
three hours. SeMet C183S-FixK2His6 was 
purified like the unlabeled protein. SeMet had 
replaced all eight methionines as confirmed by 
mass-spectrometric analysis. 
In vitro transcription activation assays. 
Multiple-round IVT activation was carried out at 
37°C as previously described (18). Briefly, 0.1 
to 1 µM of C183S-FixK2His6 in modified IVT 
buffer (40 mM Tris-HCl, pH 7, 150 mM KCl, 
0.1 mM ethylenediaminetetraacetic acid) plus 
the four nucleotide triphosphates was incubated 
in the presence of 50 nM B. japonicum RNA 
polymerase (holoenzyme) and 20 nM of 
template plasmid pRJ8816 at 37°C for 30 min. 
This plasmid harbors the fixN promoter region 
and a small part of the fixN gene upstream of a 
B. japonicum transcription terminator from the 
rrn operon. The electrophoretically separated 
transcripts were analyzed by using a 
PhosphorImager SF (Molecular Dynamics–GE 
Healthcare, Sunnyvale, USA), and signal 
intensities were determined with the Bio-Rad 
Quantity One software (Bio-Rad, Reinach, 
Switzerland). 
Crystallization. Unlabeled, native and SeMet-
labeled C183S-FixK2His6 were crystallized in 
the presence of 30mer double-strand target DNA 
from the FixK2 binding site of the fixN promoter 
(sequence: 
CCACCTATCTTGATTTCAATCAATTCCCC
G; two binding half-sites underlined). This fixN 
oligonucleotide (1 µM scale; Microsynth, 
Balgach, Switzerland) was prepared by heating 
equimolar amounts of complementary single-
strand DNAs at 98°C for 5 min and slowly 
cooling the mixture down to room temperature 
afterwards. The proteins (9 mg/ml) that had been 
purified by immobilized metal ion affinity 
chromatography were mixed with 1.5-fold molar 
excess of fixN double-strand DNA and incubated 
for 5 min on ice. The formed DNA-protein 
complex was then subjected to size-exclusion 
chromatography on a Superdex 200 10/300 HR 
column (GE Healthcare) with modified IVT 
buffer as the running buffer and concentrated 
using a microcon membrane (Amicon–Merck 
Millipore, Billerica, USA) with a molecular-
mass cutoff of 10 kDa. 
Crystals of both the native and the SeMet-
labeled FixK2 derivatives complexed with DNA 
(185 mg complex/ml) were grown at 277°K by 
sitting-drop vapor diffusion in 0.1 M BisTris, pH 
6, 0.1 M NH4-acetate, 16-22% 
polyethyleneglycol (PEG) 10,000 for a period of 
two to four days. The complex crystallized as a 
protein dimer bound to DNA, and the crystals 
were thin and plate-like (Fig. 1). 
Data collection and structure determination. 
Crystals were flash-frozen in liquid propane 
after sequential soaking in mother liquor 
containing 5–20% PEG400. Diffraction data 
were collected at 90°K at the Swiss Light Source 
X06SA beamline (Paul Scherrer Institute, 
Villigen, Switzerland) using a PILATUS 6M 
detector (Dectris, Baden, Switzerland) at a 
wavelength of 1 Å (native protein) and 0.997 Å 
(SeMet derivative). The FixK2 structure was 
solved by SAD using the SeMet-labelled 
protein. 
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Data for the native and SeMet proteins were 
processed by using software package XDS (24). 
The SeMet positions were located by using the 
program suite SHELX (25) and the phased 
electron-density map was used for automatic 
model building with AutoSol/AutoBuild using 
PHENIX (26). Manual model building was 
performed using COOT (27), and the structure 
was refined first with PHENIX and then with 
REFMAC5 from CCP4i (28), including TLS 
refinement. The structure of C183S-FixK2His6 
includes amino acids 38 to 232 (both monomers) 
of the mature 232-amino-acid protein, with one 
FixK2 dimer in the asymmetric unit. No density 
was observed for the N-terminal residues 1–37 
in either monomer. The four additional C-
terminal residues are part of the linker region 
between protein and the hexa-His affinity tag, 
which itself is not visible in the structure. 25 and 
24 of the 30 basepairs of the bound, double-
strand fixN promoter DNA were structurally 
assigned (strands W and X, respectively). The 
nucleotides at both ends that could not be 
assigned will be addressed below (i.e., two at the 
5’ end and three at the 3’ end of strand W; two at 
the 3’ end and four at the 5’ end on strand X). 
MolProbity 
(http://molprobity.biochem.duke.edu) was used 
to assess the quality of the crystal structure. The 
data collection and refinement statistics are 
presented in Table 1. Structural figures were 
generated using PyMOL (Warren L. DeLano, 
The PyMOL Molecular Graphics System, 
http://www.pymol.org).  Secondary Structure 
Matching (SSM), implemented in COOT, was 
used to compare the FixK2 structure with other 
structures of the protein superfamily.  
Accession Number. Coordinates and structure 
factors have been deposited in the Protein Data 
Bank with accession number 4I2O. 
 
RESULTS AND DISCUSSION 
Problem solving and crystallization of FixK2. 
Two major obstacles stood in the way towards 
crystallization of FixK2: the oxidation sensitivity 
of the protein and its sensitivity to proteolysis. 
Initially, an N-terminally His6-tagged wild-type 
FixK2 was used that failed to produce crystals. 
Static light-scattering analyses revealed that the 
protein solution was highly poly-disperse (data 
not shown), likely reflecting the monomer-dimer 
equilibrium of FixK2 (18) and the different 
oxidation states at cysteine 183 (19). To avoid 
oxidation, cysteine 183 was exchanged to serine 
resulting in the N-terminally His6-tagged C183S-
His6FixK2 construct. This protein variant was 
active in an IVT activation assay and resistant to 
oxidation (data not shown), but did not 
crystallize either. Furthermore, C183S-
His6FixK2 co-purified with a truncated form, 
which was identified by mass spectrometry as a 
220-amino-acid derivative lacking twelve amino 
acids from the C-terminus (named C183S-
His6FixK2-220) (Fig. 2a). Although this cleaved 
variant remained soluble, it was inactive in the 
IVT activation test (data not shown). Exchange 
of the amino acids valine 220 and leucine 221 
before and after the cleavage site against 
asparagine or threonine did not abolish cleavage. 
Cleavage was prevented, however, by using a C-
terminally His6-tagged FixK2 variant (C183S-
FixK2His6). This variant was purified with high 
yield as an apparently homogeneous, full-length 
protein (Fig. 2a; molecular mass 26,883 Da). 
Despite the relative proximity of the His6-tag to 
the DNA-binding domain, the C183S-FixK2His6 
variant was active in the IVT activation assay 
(Fig. 2b), and was successfully used in 
subsequent crystallization trials. 
As of today, three structures of proteins from 
the CRP/FNR family are available in their 
cofactor-free apo-form (6, 10, 12). The majority 
of the structures available are in complex with 
their cognate cofactor, and only two structures 
have the target DNA bound (10, 29). As no 
cofactor has been identified so far for FixK2, we 
attempted to crystallize C183S-FixK2His6 in the 
absence or presence of a 30mer double-strand 
target DNA harboring the FixK2 binding site 
from the promoter of the fixNOQP operon (17). 
Numerous crystallization conditions and 
methods, protein concentrations and 
temperatures were varied over a broad range, 
resulting finally in a condition that yielded 
crystals of C183S-FixK2His6 in complex with 
DNA. The initial crystals diffracted highly 
anisotropically to a resolution of about 3 Å. 
Fine-slicing around the pH of the original 
condition, and optimizing the cryo-conditions 
for plunge-freezing resulted in satisfactory 
crystals (Fig. 1) that diffracted to a resolution <2 
Å. We solved the structure of the C183S-
FixK2His6-DNA complex by single wavelength 
anomalous dispersion (SAD) and refined it to a 
final resolution of 1.77 Å, with R-factor and R-
free values of 18.3% and 22.7%, respectively 
(Table 1 and Fig. 3).  
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Survey on structural features. The electron 
density map allowed an unequivocal assignment 
of amino acids 38 to 232 of the 232-amino-acid 
FixK2 monomer (Fig. 3). Hence, the predicted 
secondary structure elements β1 and αA in the 
N-terminal 37-amino-acid stretch (Fig. 4) are not 
visible in the structure. All other secondary 
structure elements displayed in Fig. 4 have been 
confirmed by the crystal structure. With the N-
terminal region included, each monomer in the 
dimeric FixK2 protein contains seven alpha-
helices (αA to αG) and twelve beta-sheets (β1 to 
β12) (Fig. 4). The full-length protein comprises 
two major domains, (i) the N-terminal half 
(residues 1–127: αA–αB, and β1–β9) containing 
the double-stranded β-roll structure (residues 
41–116: β2–β9), which in other CRP/FNR 
family members corresponds to the effector-
binding domain, and (ii) the C-terminal DNA-
binding domain (residues 155–236: αD–αG, and 
β10–β12) with the winged helix-turn-helix fold 
(residues 184–216: αE and αF). The two major 
domains are connected by the long α-helix 
(residues 128–154: αC), which is involved in 
dimerization of the two monomers. The dimeric 
C183S-FixK2His6 structure displays a perfect 
twofold symmetry (Fig. 3).  For the DNA 
molecule, electron density could be seen and 
bases assigned for 25 out 30 (strand W), and 24 
out of 30 nucleotides (strand X). Due to its 
nearly perfect palindromic sequence, which is 
interrupted by four nucleotides (TTGAT–N4–
ATCAA; inverted repeat underlined) the bound 
DNA molecule displays a quasi-twofold 
symmetry.  
The overall architecture of the DNA-protein 
complex with FixK2 is largely similar to that of 
CRP and CprK (Fig. 5). Nevertheless the 
structures do not superimpose ideally, giving 
relatively high root mean square deviations 
(r.m.s.d.) of 2.08 Å (for 175 Cα atoms) and 3.27 
Å (for 177 Cα atoms) for CRP and CprK, 
respectively. These deviations can primarily be 
explained by the different arrangement of the 
DNA portion in the complexes as well as by 
differences in the C-terminal parts of the 
proteins.  
The overall surface of the FixK2 protein 
appears to exhibit an equal distribution of 
hydrophobic and hydrophilic patches. A notable 
surface feature of FixK2 is the presence of one 
negatively charged cavity per monomer (Fig. 6). 
Superimposition with CRP showed that this area 
corresponds to the hydrophobic cAMP-binding 
pocket in the CRP effector-binding domain. The 
amino acid residues forming the pockets are not 
conserved between CRP and FixK2. Although 
FixK2, in comparison with CRP, must be present 
in a higher protein concentration to be active in 
an IVT activation assay, it does not require the 
addition of a co-activating compound such as 
cAMP in the case of CRP. Previous work has 
shown that neither cAMP nor cGMP alters the 
concentration-dependent elution behavior of 
FixK2 during size-exclusion chromatography 
(18). Whether or not the aforementioned 
negatively charged cavity of FixK2 functions in 
the binding of a yet unidentified cofactor 
remains an open question. SdrP, another 
CRP/FNR family member, has also been shown 
to be active in vitro without any cofactor. SdrP 
crystallizes in an active form without DNA 
bound. Contrary to FixK2, however, its crystal 
structure clearly lacks the putative cofactor 
binding pocket (13) because bulky amino acid 
residues fill the corresponding positions where 
cAMP occupies the pocket in CRP.  
Surface-exposed C-terminus, a possible 
target for degradation. As reported above, the 
N-terminally His6-tagged C183S-FixK2 
derivative suffered a truncation during the 
purification procedure through specific 
proteolytic cleavage at the C-terminus between 
valine 220 and leucine 221. Moreover, recent 
work showed that the C-terminus in FixK2 is a 
recognition site for the ClpAP1 chaperone 
protease leading to complete degradation of the 
protein (23). Hence, the C-terminus appears to 
be a critical determinant for protease sensitivity.   
The structure of our FixK2-DNA complex 
now showed that the C-terminal helix (αG) is 
clearly surface-exposed, rendering the protein 
susceptible to specific cleavage and ClpAP1-
mediated recognition (Fig. 7). Cleavage between 
valine 220 and leucine 221 disrupts the carboxy-
end of beta-strand β12 (Fig. 4). Interestingly, 
β12 is the intermediate β-strand of a small β-
sheet formed by β10, β11, and β12 near the 
DNA-binding domain. Although this β-sheet 
does not directly interact with the bound DNA 
(Fig. 7), hydrogen bonds are formed between 
β12 and αG, and between αG and αE of the 
HTH-motif. Therefore, disrupting these 
hydrogen bonds by proteolytic removal of the 
last twelve amino acids might affect the DNA-
binding domain, leading to inactivation of the 
protein. In fact, this assumption was confirmed 
by DNA-band shift assays, in which the 
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truncated C183S-His6FixK2-220 variant was 
found to be unable to bind DNA (data not 
shown), which explains its inactivity in the IVT 
activation assay (see above).  
The C-terminal helix (αG) is also present in 
some other members of the CRP/FNR 
superfamily (CprK, 10; PrfA, 11; SdrP, 13) and 
therein plays a crucial role in DNA-binding and 
activity. In CprK, for example, the C-terminus 
interacts directly with DNA in the on-state, but 
is unstructured in the apo-form (10), and in 
PrfA, the C-terminus stabilizes the DNA binding 
domain (11). For the latter, mutations of the last 
helices were found to abolish DNA-binding, 
rendering PrfA inactive (30).  
Characteristics of protein-DNA interactions. 
As stated before, only two other structures of the 
homologues CRP (29) and CprK (10) have been 
solved in complex with their cognate DNA. The 
crystallization of C183-FixK2His6 in complex 
with a cognate target DNA allowed us to gain 
detailed insight into the interactions between 
amino acids of the HTH-motif and nucleotides 
of the so-called FixK2 box, a specific and 
conserved DNA sequence in the promoter region 
of at least 20 bona fide FixK2-activated genes 
(18, 19). The FixK2 box consists of 14 bases that 
include the minimal consensus sequence TTG–
N8–CAA. Mutations in the FixK2 box abolish 
activation of transcription by FixK2 (18). The 
structure revealed that three amino acids in helix 
αF (L195, E196, R200) of the HTH motif 
directly interact with bases of the FixK2 box 
(Fig. 8). L195 of either monomer forms a 
hydrophobic interaction with base T8 (strand W) 
and T8' (strand X). E196 of either monomer 
forms a hydrogen bond with C19 (strand W) and 
C19' on strand X (Fig. 8). Interestingly, the 
guanidinium moiety of arginine 200 interacts 
strongly by complex hydrogen bonding with two 
bases located on different strands of the DNA 
molecule. Bidentate interactions are formed with 
G10/G10’, and one additional hydrogen bond 
with T18’/T18 (monomers A/B) (Fig. 8 and Fig. 
9). These specific interactions between bases and 
amino acids are the hallmark of FixK2-DNA 
binding. Applying bioinformatics analysis, 
Dufour and co-workers (31) predicted that the 
conserved protein sequence (I/L/V)EXXXR 
applies as a DNA-binding motif for the entire 
FixK subgroup of all α-proteobacteria. Here, we 
can perfectly validate this hypothesis, since the 
FixK2 binding motif reads L195E196XXXR200 
(Fig. 4). The R200-interacting T18 and T18' 
bases are located immediately adjacent to the 
core consensus sequence TTG–N8–CAA of the 
previously defined FixK2 box, i.e., they come to 
lie within the more variable region (N8). Hence, 
a fourth nucleotide must be considered as being 
part of the FixK2-interacting DNA, such as 
TTGA-N6-T(18)CAA on strand W. To maintain a 
strong interaction with the FixK2 box, the base at 
position 18 may alternatively be a G, a 
requirement imposed by the restricted hydrogen 
bonding of an arginine side chain to either a T or 
a G (32). We therefore postulate a refined 
consensus sequence for the FixK2 box, 
TTG(A/C)–N6–(T/G)CAA, which coincides 
reasonably well with the consensus sequence 
deduced from an alignment of approved FixK2 
box-associated promoter sequences (16). 
A similar complex DNA-protein interaction 
network can be found for CRP. As in FixK2, in 
CRP the second helix of the HTH motif 
penetrates the major groove of the DNA, and 
three conserved specific amino acid side chains 
(R180, E181, R185) interact directly via 
hydrogen bonds with DNA-bases, forming a 
REXXXR motif. These specific residues 
perfectly superimpose with the LEXXXR 
binding sequence in FixK2. Despite a similar 
primary recognition pattern the DNA in the 
FixK2 complex structure is less bent, 
approximately 55°. In contrast, the observed 
DNA bend in the CRP complex structure is 90° 
(PDB 1J59; 14). As in the CRP structure, the 
DNA bend in the FixK2 structure contains two 
sharp primary kinks between the pseudo 
symmetry-related nucleotide pairs W T9 and W 
G10, and W C19 and W A20. Two secondary 
kinks are also formed: W G3 and W G4, and W 
A25 and W G26. In general, the required energy 
to bend the DNA is compensated by the very 
specific interactions as described above and 
between protein side chains and the DNA 
phosphates. Several indirect protein-DNA 
interactions were also observed (Fig. 8). These 
are located in the short loop between the 
dimerization helix αC and helix αD, as well as 
in the HTH-motif and nearby. The interactions 
occur through side chain residues and the DNA-
phosphate backbone or via water molecules, and 
in a few cases via the amino acid peptide bond 
and the DNA phosphodiester bond (Fig. 8). 
These additional interactions, especially the 
hydrogen bonds located in the inter-αC–αD 
loop, might contribute to positioning the HTH-
motif in an appropriate conformation for DNA 
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binding. It has been observed in other 
CRP/FNR-family proteins (CRP, CprK, NtcA) 
that the position of αF in the HTH-motif and, 
hence, its orientation towards the major groove 
of DNA may change after co-factor binding, 
which in these proteins is a pre-requisite for the 
association with DNA (10, 12, 15, 29, 33). 
Although CRP and FixK2 exhibit a similar 
number of hydrogen-bond and ionic interactions 
between the protein side chains and the DNA 
phosphates, the ones in CRP are more frequently 
near the secondary kink, which might explain 
the stronger bending of bound DNA.  
The critical role of cysteine 183 in the 
oxidative control of the FixK2 protein.  One of 
the regulatory complexes for low-oxygen 
sensing and signal transduction in B. japonicum 
is a two-component regulatory system, FixLJ, 
which controls the activation of the fixK2 gene 
(17). Once expressed, the FixK2 protein then 
activates the expression of a large number of 
genes for microoxic and anoxic energy 
metabolism (17). Such a sequentially operating 
cascade of positive controls asks for a negative 
control that keeps gene expression balanced 
according to needs. We have previously 
discovered that ROS negatively interfere with 
FixK2 by inhibiting its activity through oxidation 
of the single cysteine at position 183 in the 
protein (19). Here, we were interested to see if 
the structure of the FixK2-DNA complex could 
explain how oxidation of C183 blocks activity.   
 In the crystallized C183S-FixK2 variant the 
serine hydroxyl replaces the oxidation-sensitive 
cysteine thiol. As shown in Fig. 10, the S183 is 
clearly surface-exposed. It is therefore 
conceivable that C183 in the equivalent position 
of the wild-type protein is readily accessible for 
oxidation. In monomer A of the C183S-FixK2 
structure, the side-chain oxygen of S183 is 4.5 Å 
away from the phosphodiester between 
nucleotides A6 and A7 (Fig. 11), which 
corresponds to the T6'–C7' phosphate backbone 
near monomer B. Given that the Van der Waals 
radius of sulfur (rw = 1.8 Å) is larger than that of 
the oxygen in S183 (rw = 1.52 Å), the C183 thiol 
is predicted to be even closer to the DNA 
phosphate backbone. Thereby, C183 might 
partially fill the space between protein and 
DNA, yet allowing sufficient distance to the 
phosphate backbone of DNA.  
Upon ROS-mediated oxidation, the 
conversion of the C183 thiol into sulfinic (–SO2–
) or sulfonic acid derivatives (–SO3–) has serious 
consequences. As a corollary of thiol oxidation, 
the more bulky, negatively charged sulfoxides 
will not only cause a steric hindrance of the 
protein-DNA interaction but also an electrostatic 
repulsion of the opposite, negatively charged 
DNA phosphate, preventing FixK2 binding to 
DNA or at least DNA bending. However, we 
cannot completely exclude that such a chemical 
modification might contribute to a 
conformational change of the DNA-binding 
domain, thus resulting in a loss of target DNA 
recognition. 
Previous work has shown that strong over-
oxidation of FixK2 also affects methionines, 
which become oxidized to methionine 
sulfoxides. It was not known, however, how 
many and which of the eight methionines in each 
FixK2 monomer had been targeted (19). The 
structure now shows that only methionine 177 is 
surface-exposed (Fig. 10), which makes it a 
prime candidate for oxidation besides C183. 
However, since M177 is 10 Å away from the 
nearest DNA phosphate backbone, its 
irreversible oxidation might not obstruct DNA 
binding directly. This is corroborated by the fact 
that treatment of a C183A-FixK2 variant with 
0.1 mM hydrogen peroxide, a condition that 
leads to protein methionine oxidation, did not 
inhibit the transcription-activating activity of 
FixK2 (19). Thus, C183 is undoubtedly the most 
sensitive target, whose oxidation renders FixK2 
inactive. 
In conclusion, the surface exposure of the 
single cysteine 183 and the proximity of the 
side-chain thiol to DNA, when FixK2 is bound to 
the FixK2-box, are the two key features that 
explain why ROS inhibits this transcription 
factor post-translationally. Oxidation-sensitive 
cysteine thiols have also been described for the 
Desulfitobacterium dehalogenans CprK protein, 
but these form either intra- or inter-subunit 
disulfide bridges upon oxidation (10). 
Interestingly, inhibition of a regulatory protein 
via one cysteine (C179) has recently been 
described for the B. japonicum OsrA protein, 
which is an anti-sigma factor of the EcfF sigma 
factor (34). To the best of our knowledge, our 
investigation on FixK2 is the first known 
example for a member of the CRP/FNR 
superfamily where this kind of modification has 
found a structural explanation.  
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FIGURE LEGENDS 
	  
FIGURE 1. Crystals of the C183S-FixK2His6 protein in complex with DNA. The thin and platelike 
crystals were grown by vapour diffusion in 0.1 M BisTris, pH 6, 0.1 M NH4-acetate, 16-22% PEG 
10,000 at 277°K within 2–4 days. The scale bar corresponds to 200 µm.   
FIGURE 2. Tests for purity and activity of the C183S-FixK2His6 protein. (a) Coomassie blue-stained 
gel after SDS-polyacrylamide gel electrophoresis of purified N-terminally and C-terminally His6-
tagged C183S-FixK2 proteins. The N-terminally tagged construct co-purifies with a truncated version 
(C183S-His6FixK2-220) that lacks the twelve C-terminal amino acids. (b) IVT activation assay with 
0.1 to 1 µM of C183S-FixK2His6 added to the test mixture. Plasmid template (pRJ8816) containing 
the FixK2-dependent fixN promoter cloned upstream of a strong transcription terminator was used for 
multiple-round in vitro transcription with RNA polymerase holoenzyme from B. japonicum. A FixK2-
independent transcript encoded by the plasmid served as a useful internal control for the RNA 
polymerase activity. The left two lanes contain RNA size markers with lengths of 180 (M) and 286 
nucleotides (M'). 
 
FIGURE 3. Ribbon representation of the C183S-FixK2His6 protein bound to FixK2 box-containing 
target DNA. The protein-DNA complex crystallized in space group P21. The structure was solved by 
SAD methods and refined to 1.77 Å with R-factor and R-free values of 18.3% and 22.7%, 
respectively. Due to the lack of electron density at the N-terminus, the first 37 amino acids of C183S-
FixK2His6 could not be modelled. Likewise, few nucleotides at both ends of the 30mer DNA could 
not be structurally determined (see Experimental Procedures). The two monomers are shown in red 
and blue and some important secondary structure elements have been labelled, i.e. the dimerization 
helix αC, and αF from the HTH-motif harbouring the DNA-binding sequence L195E196XXXR200. The 
figure was generated using Pymol (http://www.pymol.org).  
 
FIGURE 4. Secondary structure of FixK2. The secondary structure elements (determined with DSSM 
using the structure of C183S-FixK2His6) are colored in red (α-helices) and blue (β-strands). Amino 
acid residues and secondary structure elements (predicted from the sequence using PSIPred) that are 
not seen in the solved structure due to the lack of electron density are depicted in light coloration. 
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Further structural elements relevant for this work are highlighted as follows: frame, HTH motif; white 
letters, amino acids in the LEXXXR motif of helix αF making contact with DNA at FixK2 box; 
asterisk, oxidation-sensitive cysteine 183; underlining, the 12 amino acids that are cleaved off when 
the C-terminus is not protected by a His6-tag.  
 
FIGURE 5. Superimposition of C183S-FixK2His6 (red colour), CRP (green colour, 1J5914) and CprK 
(blue colour, 3E6C10). The overall architecture of the homologues protein is largely similar, 
displaying the same overall structural fold. However, CRP and CprK show a stronger DNA-bending 
(90° and 80°, respectively) than C183S-FixK2His6 (approximately 55°). 
FIGURE 6. Electrostatic surface of C183S-FixK2His6. The structure is shown in two different 
orientations, related by a 90° rotation along the y-axis. Red indicates negatively charged regions (–12 
kT) and blue positively charged regions (+12 kT). Uncharged surfaces are shown in white. The 
surface shows a negatively charged cavity (encircled) that superimposes well with the cAMP binding 
pocket of CRP. The image was generated using the APBS tool in Pymol.  
FIGURE 7. Top view of the structure of C183S-FixK2His6 in complex DNA. The two monomers are 
shown in red and blue. The twelve C-terminal amino acids of the protein are colored in yellow. They 
are surface exposed, rendering the protein accessible to specific proteolytic cleavage and complete 
degradation. The three β-strands near the protease-sensitive site (β10 to β12) are marked on one 
monomer, and the entire β-sheet is encircled. 
 
FIGURE 8. Schematic representation of information on the contact sites between FixK2 protein and 
target DNA deduced from the high-resolution structure. Amino acids that undergo specific 
interactions with nucleotides are marked with boldface letters. The core FixK2 box is underlined. The 
grey nucleotides at both ends are those that could not be modelled due to lack of electron density. The 
types of interactions are indicated in the lower left corner.  
 
FIGURE 9. Selected section of the structure around arginine 200 (monomer A), showing the complex 
hydrogen bond interactions to two bases of opposite DNA strands, i.e., G10 on strand W, and T18’ on 
strand X. 
FIGURE 10. Surface representation of C183S-FixK2His6 protein bound to DNA. The two monomers 
are shown in red and blue. Serine 183 is surface exposed and in close proximity to the DNA. In the 
wild-type protein, oxidation of C183 at this position most likely inactivates the protein through steric 
hindrance of DNA binding or electrostatic repulsion of the DNA. Methionine 177 is highlighted as 
well, being the only one out of eight methionines that is located on the surface of the protein. Met 177 
is accessible to oxidation, but its oxidation does not influence protein activity.  
 
FIGURE 11. Selected electron density map. The sector around serine 183 is shown. The final 2Fo-Fc 
map is contoured at 1 σ and superimposed on the atomic model. The distance to the nearest phosphate 
of DNA is given.  
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TABLE 1 
Statistics of data collection and structural refinement of native and SeMet C183S-FixK2His6-DNA 
complex 
 
Data collection SeMet C183S-      
FixK2His6 (SAD data) 
Native C183S-FixK2His6 
Wavelength (Å) 
Resolution range (Å) 
Spacegroup 
Cell dimensions 
a,b,c (Å) 
α,β,γ (°) 
Unique reflectionsa        
Redundancya            
Completenessa (%)      
<I/σ(I)>a                                             
0.97961 
43.97-3.00 (3.08-3.00) 
P1211 
  
111.48, 43.97, 69.92  
90, 89.98, 90 
26587 (1987) 
9.5 (9.5) 
99.9 (100) 
17.08 (4.66) 
1.00002 
43.58-1.77 (1.83-1.77) 
P1211 
 
111.33, 43.88, 70.11  
90, 90.04, 90 
66473 (6610) 
6.6 (6.8) 
99.7 (100) 
21.82 (3.8) 
 
Refinement  
No. reflections (work set/test set) 
Rfactorb/Rfreec (%) 
No. of atoms 
       Protein (chains A/B) 
       DNA (strands W/X) 
       water  
AverageB factor (Å2) 
       Protein (chains A/B) 
       DNA (strands W/X) 
       water 
Wilson B 
Rmsd from ideal 
     Bond lengths (Å) 
     Bond angles  (°) 
Ramachandran plot   
     favored (%) 
     allowed regions (%) 
 
66510/3315 
18.30/22.71 
 
1541/1541 
522/478           
496 
 
30.7/30.7 
57.2/52.7 
40.4 
23.76 
 
0.018 
2.064 
 
98.98 
1.02 
 
 
 
aValues in parentheses refer to the outermost resolution shell. bRfactor = ∑h |Fo – Fc| / ∑h|Fo|, where Fo 
and Fc are the observed and calculated structure-factor amplitudes for each reflection h. cRfree was 
calculated for a randomly selected 10% of data omitted from refinement. 
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